EverSource Wealth Advisors’s Legend Biotech LEGN Stock Holding History

EverSource Wealth Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.6K	Buy	781 +438	+128%	+$11.8K	﹤0.01%	2345
2026 Q1	$6.2K	Buy	343 +13	+4%	+$248	﹤0.01%	3164
2025 Q4	$7.17K	Sell	330 -281	-46%	-$8.05K	﹤0.01%	2959
2025 Q3	$19.9K	Sell	611 -223	-27%	-$8.23K	﹤0.01%	2356
2025 Q2	$29.6K	Buy	834 +121	+17%	+$3.92K	﹤0.01%	1986
2025 Q1	$24.2K	Buy	713 +6	+0.8%	+$215	﹤0.01%	1593
2024 Q4	$23K	Buy	707 +499	+240%	+$20.7K	﹤0.01%	1547
2024 Q3	$10.1K	Buy	208 +1	+0.5%	+$53	﹤0.01%	1858
2024 Q2	$11.7K	Buy	207 +155	+298%	+$7.15K	﹤0.01%	1766
2024 Q1	$2.27K	Buy	52 +27	+108%	+$1.63K	﹤0.01%	2334
2023 Q4	$1.5K	Buy	+25	New	+$1.58K	﹤0.01%	2264
2023 Q3	–	Sell	-14	Closed	-$966	–	2593
2023 Q2	$966	Buy	+14	New	+$915	﹤0.01%	2241

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

EverSource Wealth Advisors's LEGN Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Legend Biotech (LEGN) stake by 128% in Q2 2026, buying an estimated $11.8K and bringing the position to 781 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2345.

EverSource Wealth Advisors first reported a position in LEGN in Q2 2023 and has held it in 12 quarters since. The position peaked at $29.6K in Q2 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

EverSource Wealth Advisors held 781 shares of Legend Biotech worth $22.6K as of Q2 2026.
EverSource Wealth Advisors bought 438 Legend Biotech shares in Q2 2026, an estimated $11.8K.
Legend Biotech made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2345 holding.
EverSource Wealth Advisors first reported a position in Legend Biotech in Q2 2023 and has held it in 12 quarters since.
EverSource Wealth Advisors's Legend Biotech position peaked at $29.6K in Q2 2025.
219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.